132 related articles for article (PubMed ID: 33516809)
1. The µ-δ opioid heteromer masks latent pain sensitization in neuropathic and inflammatory pain in male and female mice.
Inyang KE; George SR; Laumet G
Brain Res; 2021 Apr; 1756():147298. PubMed ID: 33516809
[TBL] [Abstract][Full Text] [Related]
2. HDAC6 Inhibition Reverses Cisplatin-Induced Mechanical Hypersensitivity via Tonic Delta Opioid Receptor Signaling.
Zhang J; Junigan JM; Trinh R; Kavelaars A; Heijnen CJ; Grace PM
J Neurosci; 2022 Oct; 42(42):7862-7874. PubMed ID: 36096670
[TBL] [Abstract][Full Text] [Related]
3. Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive Activity.
Walwyn WM; Chen W; Kim H; Minasyan A; Ennes HS; McRoberts JA; Marvizón JC
J Neurosci; 2016 Jan; 36(1):204-21. PubMed ID: 26740662
[TBL] [Abstract][Full Text] [Related]
4. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
Gomes I; Fujita W; Gupta A; Saldanha SA; Negri A; Pinello CE; Eberhart C; Roberts E; Filizola M; Hodder P; Devi LA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12072-7. PubMed ID: 23818586
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens.
Kabli N; Nguyen T; Balboni G; O'Dowd BF; George SR
Mol Psychiatry; 2014 Sep; 19(9):986-94. PubMed ID: 24061495
[TBL] [Abstract][Full Text] [Related]
6. Postsurgical Latent Pain Sensitization Is Driven by Descending Serotonergic Facilitation and Masked by µ-Opioid Receptor Constitutive Activity in the Rostral Ventromedial Medulla.
Cooper AH; Hedden NS; Prasoon P; Qi Y; Taylor BK
J Neurosci; 2022 Jul; 42(30):5870-5881. PubMed ID: 35701159
[TBL] [Abstract][Full Text] [Related]
7. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
[TBL] [Abstract][Full Text] [Related]
8. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
9. Endogenous µ-opioid receptor activity in the lateral and capsular subdivisions of the right central nucleus of the amygdala prevents chronic postoperative pain.
Cooper AH; Hedden NS; Corder G; Lamerand SR; Donahue RR; Morales-Medina JC; Selan L; Prasoon P; Taylor BK
J Neurosci Res; 2022 Jan; 100(1):48-65. PubMed ID: 33957003
[TBL] [Abstract][Full Text] [Related]
10. Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents.
Tiwari V; He SQ; Huang Q; Liang L; Yang F; Chen Z; Tiwari V; Fujita W; Devi LA; Dong X; Guan Y; Raja SN
Pain; 2020 Apr; 161(4):842-855. PubMed ID: 31815916
[TBL] [Abstract][Full Text] [Related]
11. Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial.
Pereira MP; Werner MU; Dahl JB
Trials; 2015 Nov; 16():511. PubMed ID: 26554360
[TBL] [Abstract][Full Text] [Related]
12. A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.
Lei W; Vekariya RH; Ananthan S; Streicher JM
J Pain; 2020; 21(1-2):146-160. PubMed ID: 31201990
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in kappa opioid receptor inhibition of latent postoperative pain sensitization in dorsal horn.
Custodio-Patsey L; Donahue RR; Fu W; Lambert J; Smith BN; Taylor BK
Neuropharmacology; 2020 Feb; 163():107726. PubMed ID: 31351975
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of the peripheral Mu-opioid system in antinociception induced by bergamot essential oil to allodynia after peripheral nerve injury.
Komatsu T; Katsuyama S; Uezono Y; Sakurada C; Tsuzuki M; Hamamura K; Bagetta G; Sakurada S; Sakurada T
Neurosci Lett; 2018 Nov; 686():127-132. PubMed ID: 30201308
[TBL] [Abstract][Full Text] [Related]
15. Anti-analgesic effect of the mu/delta opioid receptor heteromer revealed by ligand-biased antagonism.
Milan-Lobo L; Enquist J; van Rijn RM; Whistler JL
PLoS One; 2013; 8(3):e58362. PubMed ID: 23554887
[TBL] [Abstract][Full Text] [Related]
16. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
Beaudry H; Gendron L; Morón JA
Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
[TBL] [Abstract][Full Text] [Related]
17. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
Largent-Milnes TM; Guo W; Wang HY; Burns LH; Vanderah TW
J Pain; 2008 Aug; 9(8):700-13. PubMed ID: 18468954
[TBL] [Abstract][Full Text] [Related]
18. The bivalent ligand MCC22 potently attenuates hyperalgesia in a mouse model of cisplatin-evoked neuropathic pain without tolerance or reward.
Cataldo G; Erb SJ; Lunzer MM; Luong N; Akgün E; Portoghese PS; Olson JK; Simone DA
Neuropharmacology; 2019 Nov; 158():107598. PubMed ID: 30970233
[TBL] [Abstract][Full Text] [Related]
19. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
20. Mu-opioid receptors are not involved in acute cocaine-induced locomotor activity nor in development of cocaine-induced behavioral sensitization in mice.
Lesscher HM; Hordijk M; Bondar NP; Alekseyenko OV; Burbach JP; van Ree JM; Gerrits MA
Neuropsychopharmacology; 2005 Feb; 30(2):278-85. PubMed ID: 15257307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
